Medical Care
Global Tuberculosis (TB) Diagnostics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 12, 25
- ID: 307384
- Pages: 128
- Figures: 117
- Views: 4
In 2024, the global market size of Tuberculosis (TB) Diagnostics was estimated to be worth US$ 2870 million and is forecast to reach approximately US$ 3889 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tuberculosis (TB) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis (TB) Diagnostics.
The Tuberculosis (TB) Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tuberculosis (TB) Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis (TB) Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
Segment by Type
Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others
Segment by Application
Diagnostic Laboratories
Hospitals
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Tuberculosis (TB) Diagnostics in global and regional level.
Chapter 3: Detailed analysis of Tuberculosis (TB) Diagnostics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tuberculosis (TB) Diagnostics revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tuberculosis (TB) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis (TB) Diagnostics.
The Tuberculosis (TB) Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tuberculosis (TB) Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis (TB) Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
Segment by Type
Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others
Segment by Application
Diagnostic Laboratories
Hospitals
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Tuberculosis (TB) Diagnostics in global and regional level.
Chapter 3: Detailed analysis of Tuberculosis (TB) Diagnostics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tuberculosis (TB) Diagnostics revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Tuberculosis (TB) Diagnostics Product Introduction
1.2 Market by Type
1.2.1 Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Culture-Based Diagnostics
1.2.3 Sputum Smear Microscopy
1.2.4 Rapid Molecular Diagnostics
1.2.5 Others
1.3 Market by Application
1.3.1 Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Tuberculosis (TB) Diagnostics Market Size Estimates and Forecasts
2.2 Tuberculosis (TB) Diagnostics Market Size by Region: 2024 Versus 2031
2.2.1 Global Tuberculosis (TB) Diagnostics Revenue by Region: 2020-2025
2.2.2 Global Tuberculosis (TB) Diagnostics Revenue Forecast by Region (2026-2031)
2.2.3 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Tuberculosis (TB) Diagnostics Revenue by Type (2020-2031)
3.1.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Tuberculosis (TB) Diagnostics Revenue by Application (2020-2031)
3.2.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Culture-Based Diagnostics of Tuberculosis (TB) Diagnostics Revenue Market Share by Application
3.3.2 Sputum Smear Microscopy of Tuberculosis (TB) Diagnostics Revenue Market Share by Application
3.3.3 Rapid Molecular Diagnostics of Tuberculosis (TB) Diagnostics Revenue Market Share by Application
3.3.4 Others of Tuberculosis (TB) Diagnostics Revenue Market Share by Application
4 Global Tuberculosis (TB) Diagnostics by Company
4.1 Global Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025)
4.2 Global Tuberculosis (TB) Diagnostics Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Tuberculosis (TB) Diagnostics Companies around the World: Ranking by Revenue
4.3.2 Global Tuberculosis (TB) Diagnostics Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Tuberculosis (TB) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Tuberculosis (TB) Diagnostics Companies Headquarters & Product Type
4.4.1 Global Tuberculosis (TB) Diagnostics Companies Headquarters
4.4.2 Date of International Companies Enter into Tuberculosis (TB) Diagnostics Market
4.4.3 Global Tuberculosis (TB) Diagnostics Companies Product & Service
4.4.4 Culture-Based Diagnostics Revenue Market Share of Tuberculosis (TB) Diagnostics by Company
4.4.5 Sputum Smear Microscopy Revenue Market Share of Tuberculosis (TB) Diagnostics by Company
4.4.6 Rapid Molecular Diagnostics Revenue Market Share of Tuberculosis (TB) Diagnostics by Company
4.4.7 Others Revenue Market Share of Tuberculosis (TB) Diagnostics by Company
4.5 Global Tuberculosis (TB) Diagnostics Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Danaher
5.1.1 Danaher Corporation Information
5.1.2 Danaher Description, Business Overview
5.1.3 Danaher Tuberculosis (TB) Diagnostics Products Offered
5.1.4 Danaher Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2020-2025)
5.1.5 Danaher Tuberculosis (TB) Diagnostics Revenue by Product in 2024
5.1.6 Danaher Tuberculosis (TB) Diagnostics Revenue by Application in 2024
5.1.7 Danaher Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2024
5.1.8 Danaher Recent Developments
5.2 Roche
5.2.1 Roche Corporation Information
5.2.2 Roche Description, Business Overview
5.2.3 Roche Tuberculosis (TB) Diagnostics Products Offered
5.2.4 Roche Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2020-2025)
5.2.5 Roche Tuberculosis (TB) Diagnostics Revenue by Product in 2024
5.2.6 Roche Tuberculosis (TB) Diagnostics Revenue by Application in 2024
5.2.7 Roche Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2024
5.2.8 Roche Recent Developments
5.3 Thermo Fisher Scientific
5.3.1 Thermo Fisher Scientific Corporation Information
5.3.2 Thermo Fisher Scientific Description, Business Overview
5.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Products Offered
5.3.4 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2020-2025)
5.3.5 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue by Product in 2024
5.3.6 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue by Application in 2024
5.3.7 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2024
5.3.8 Thermo Fisher Scientific Recent Developments
5.4 BD
5.4.1 BD Corporation Information
5.4.2 BD Description, Business Overview
5.4.3 BD Tuberculosis (TB) Diagnostics Products Offered
5.4.4 BD Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2020-2025)
5.4.5 BD Tuberculosis (TB) Diagnostics Revenue by Product in 2024
5.4.6 BD Tuberculosis (TB) Diagnostics Revenue by Application in 2024
5.4.7 BD Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2024
5.4.8 BD Recent Developments
5.5 Abbott
5.5.1 Abbott Corporation Information
5.5.2 Abbott Description, Business Overview
5.5.3 Abbott Tuberculosis (TB) Diagnostics Products Offered
5.5.4 Abbott Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2020-2025)
5.5.5 Abbott Tuberculosis (TB) Diagnostics Revenue by Product in 2024
5.5.6 Abbott Tuberculosis (TB) Diagnostics Revenue by Application in 2024
5.5.7 Abbott Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2024
5.5.8 Abbott Recent Developments
5.6 Hologic
5.6.1 Hologic Corporation Information
5.6.2 Hologic Description, Business Overview
5.6.3 Hologic Tuberculosis (TB) Diagnostics Products Offered
5.6.4 Hologic Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2020-2025)
5.6.5 Hologic Tuberculosis (TB) Diagnostics Revenue by Product in 2024
5.6.6 Hologic Tuberculosis (TB) Diagnostics Revenue by Application in 2024
5.6.7 Hologic Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2024
5.6.8 Hologic Recent Developments
5.7 Qiagen
5.7.1 Qiagen Corporation Information
5.7.2 Qiagen Description, Business Overview
5.7.3 Qiagen Tuberculosis (TB) Diagnostics Products Offered
5.7.4 Qiagen Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2020-2025)
5.7.5 Qiagen Tuberculosis (TB) Diagnostics Revenue by Product in 2024
5.7.6 Qiagen Tuberculosis (TB) Diagnostics Revenue by Application in 2024
5.7.7 Qiagen Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2024
5.7.8 Qiagen Recent Developments
5.8 BioMerieux
5.8.1 BioMerieux Corporation Information
5.8.2 BioMerieux Description, Business Overview
5.8.3 BioMerieux Tuberculosis (TB) Diagnostics Products Offered
5.8.4 BioMerieux Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2020-2025)
5.8.5 BioMerieux Tuberculosis (TB) Diagnostics Revenue by Product in 2024
5.8.6 BioMerieux Tuberculosis (TB) Diagnostics Revenue by Application in 2024
5.8.7 BioMerieux Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2024
5.8.8 BioMerieux Recent Developments
5.9 Hain Lifescience
5.9.1 Hain Lifescience Corporation Information
5.9.2 Hain Lifescience Description, Business Overview
5.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Products Offered
5.9.4 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2020-2025)
5.9.5 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue by Product in 2024
5.9.6 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue by Application in 2024
5.9.7 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2024
5.9.8 Hain Lifescience Recent Developments
5.10 Oxford Immunotec
5.10.1 Oxford Immunotec Corporation Information
5.10.2 Oxford Immunotec Description, Business Overview
5.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Products Offered
5.10.4 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2020-2025)
5.10.5 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue by Product in 2024
5.10.6 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue by Application in 2024
5.10.7 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2024
5.10.8 Oxford Immunotec Recent Developments
6 North America
6.1 North America Tuberculosis (TB) Diagnostics Market Size YoY Growth 2020-2031
6.2 North America Tuberculosis (TB) Diagnostics Market Facts & Figures by Country (2020-2031)
6.3 North America Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025)
6.4 North America Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Tuberculosis (TB) Diagnostics Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025)
7.4 Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025)
8 Europe
8.1 Europe Tuberculosis (TB) Diagnostics Market Size YoY Growth 2020-2031
8.2 Europe Tuberculosis (TB) Diagnostics Market Facts & Figures by Country (2020-2031)
8.3 Europe Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025)
8.4 Europe Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Tuberculosis (TB) Diagnostics Market Size YoY Growth 2020-2031
9.2 Latin America Tuberculosis (TB) Diagnostics Market Facts & Figures by Country (2020-2031)
9.3 Latin America Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025)
9.4 Latin America Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Tuberculosis (TB) Diagnostics Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Tuberculosis (TB) Diagnostics Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025)
10.4 Middle East and Africa Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Tuberculosis (TB) Diagnostics Supply Chain Analysis
11.2 Tuberculosis (TB) Diagnostics Key Raw Materials and Upstream Suppliers
11.3 Tuberculosis (TB) Diagnostics Clients Analysis
11.4 Tuberculosis (TB) Diagnostics Sales Channel and Sales Model Analysis
11.4.1 Tuberculosis (TB) Diagnostics Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Tuberculosis (TB) Diagnostics Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Tuberculosis (TB) Diagnostics Distributors
12 Tuberculosis (TB) Diagnostics Market Dynamics
12.1 Tuberculosis (TB) Diagnostics Industry Trends
12.2 Tuberculosis (TB) Diagnostics Market Drivers
12.3 Tuberculosis (TB) Diagnostics Market Challenges
12.4 Tuberculosis (TB) Diagnostics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Tuberculosis (TB) Diagnostics Product Introduction
1.2 Market by Type
1.2.1 Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Culture-Based Diagnostics
1.2.3 Sputum Smear Microscopy
1.2.4 Rapid Molecular Diagnostics
1.2.5 Others
1.3 Market by Application
1.3.1 Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Tuberculosis (TB) Diagnostics Market Size Estimates and Forecasts
2.2 Tuberculosis (TB) Diagnostics Market Size by Region: 2024 Versus 2031
2.2.1 Global Tuberculosis (TB) Diagnostics Revenue by Region: 2020-2025
2.2.2 Global Tuberculosis (TB) Diagnostics Revenue Forecast by Region (2026-2031)
2.2.3 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Tuberculosis (TB) Diagnostics Revenue by Type (2020-2031)
3.1.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Tuberculosis (TB) Diagnostics Revenue by Application (2020-2031)
3.2.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Culture-Based Diagnostics of Tuberculosis (TB) Diagnostics Revenue Market Share by Application
3.3.2 Sputum Smear Microscopy of Tuberculosis (TB) Diagnostics Revenue Market Share by Application
3.3.3 Rapid Molecular Diagnostics of Tuberculosis (TB) Diagnostics Revenue Market Share by Application
3.3.4 Others of Tuberculosis (TB) Diagnostics Revenue Market Share by Application
4 Global Tuberculosis (TB) Diagnostics by Company
4.1 Global Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025)
4.2 Global Tuberculosis (TB) Diagnostics Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Tuberculosis (TB) Diagnostics Companies around the World: Ranking by Revenue
4.3.2 Global Tuberculosis (TB) Diagnostics Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Tuberculosis (TB) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Tuberculosis (TB) Diagnostics Companies Headquarters & Product Type
4.4.1 Global Tuberculosis (TB) Diagnostics Companies Headquarters
4.4.2 Date of International Companies Enter into Tuberculosis (TB) Diagnostics Market
4.4.3 Global Tuberculosis (TB) Diagnostics Companies Product & Service
4.4.4 Culture-Based Diagnostics Revenue Market Share of Tuberculosis (TB) Diagnostics by Company
4.4.5 Sputum Smear Microscopy Revenue Market Share of Tuberculosis (TB) Diagnostics by Company
4.4.6 Rapid Molecular Diagnostics Revenue Market Share of Tuberculosis (TB) Diagnostics by Company
4.4.7 Others Revenue Market Share of Tuberculosis (TB) Diagnostics by Company
4.5 Global Tuberculosis (TB) Diagnostics Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Danaher
5.1.1 Danaher Corporation Information
5.1.2 Danaher Description, Business Overview
5.1.3 Danaher Tuberculosis (TB) Diagnostics Products Offered
5.1.4 Danaher Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2020-2025)
5.1.5 Danaher Tuberculosis (TB) Diagnostics Revenue by Product in 2024
5.1.6 Danaher Tuberculosis (TB) Diagnostics Revenue by Application in 2024
5.1.7 Danaher Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2024
5.1.8 Danaher Recent Developments
5.2 Roche
5.2.1 Roche Corporation Information
5.2.2 Roche Description, Business Overview
5.2.3 Roche Tuberculosis (TB) Diagnostics Products Offered
5.2.4 Roche Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2020-2025)
5.2.5 Roche Tuberculosis (TB) Diagnostics Revenue by Product in 2024
5.2.6 Roche Tuberculosis (TB) Diagnostics Revenue by Application in 2024
5.2.7 Roche Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2024
5.2.8 Roche Recent Developments
5.3 Thermo Fisher Scientific
5.3.1 Thermo Fisher Scientific Corporation Information
5.3.2 Thermo Fisher Scientific Description, Business Overview
5.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Products Offered
5.3.4 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2020-2025)
5.3.5 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue by Product in 2024
5.3.6 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue by Application in 2024
5.3.7 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2024
5.3.8 Thermo Fisher Scientific Recent Developments
5.4 BD
5.4.1 BD Corporation Information
5.4.2 BD Description, Business Overview
5.4.3 BD Tuberculosis (TB) Diagnostics Products Offered
5.4.4 BD Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2020-2025)
5.4.5 BD Tuberculosis (TB) Diagnostics Revenue by Product in 2024
5.4.6 BD Tuberculosis (TB) Diagnostics Revenue by Application in 2024
5.4.7 BD Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2024
5.4.8 BD Recent Developments
5.5 Abbott
5.5.1 Abbott Corporation Information
5.5.2 Abbott Description, Business Overview
5.5.3 Abbott Tuberculosis (TB) Diagnostics Products Offered
5.5.4 Abbott Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2020-2025)
5.5.5 Abbott Tuberculosis (TB) Diagnostics Revenue by Product in 2024
5.5.6 Abbott Tuberculosis (TB) Diagnostics Revenue by Application in 2024
5.5.7 Abbott Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2024
5.5.8 Abbott Recent Developments
5.6 Hologic
5.6.1 Hologic Corporation Information
5.6.2 Hologic Description, Business Overview
5.6.3 Hologic Tuberculosis (TB) Diagnostics Products Offered
5.6.4 Hologic Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2020-2025)
5.6.5 Hologic Tuberculosis (TB) Diagnostics Revenue by Product in 2024
5.6.6 Hologic Tuberculosis (TB) Diagnostics Revenue by Application in 2024
5.6.7 Hologic Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2024
5.6.8 Hologic Recent Developments
5.7 Qiagen
5.7.1 Qiagen Corporation Information
5.7.2 Qiagen Description, Business Overview
5.7.3 Qiagen Tuberculosis (TB) Diagnostics Products Offered
5.7.4 Qiagen Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2020-2025)
5.7.5 Qiagen Tuberculosis (TB) Diagnostics Revenue by Product in 2024
5.7.6 Qiagen Tuberculosis (TB) Diagnostics Revenue by Application in 2024
5.7.7 Qiagen Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2024
5.7.8 Qiagen Recent Developments
5.8 BioMerieux
5.8.1 BioMerieux Corporation Information
5.8.2 BioMerieux Description, Business Overview
5.8.3 BioMerieux Tuberculosis (TB) Diagnostics Products Offered
5.8.4 BioMerieux Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2020-2025)
5.8.5 BioMerieux Tuberculosis (TB) Diagnostics Revenue by Product in 2024
5.8.6 BioMerieux Tuberculosis (TB) Diagnostics Revenue by Application in 2024
5.8.7 BioMerieux Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2024
5.8.8 BioMerieux Recent Developments
5.9 Hain Lifescience
5.9.1 Hain Lifescience Corporation Information
5.9.2 Hain Lifescience Description, Business Overview
5.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Products Offered
5.9.4 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2020-2025)
5.9.5 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue by Product in 2024
5.9.6 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue by Application in 2024
5.9.7 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2024
5.9.8 Hain Lifescience Recent Developments
5.10 Oxford Immunotec
5.10.1 Oxford Immunotec Corporation Information
5.10.2 Oxford Immunotec Description, Business Overview
5.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Products Offered
5.10.4 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2020-2025)
5.10.5 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue by Product in 2024
5.10.6 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue by Application in 2024
5.10.7 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2024
5.10.8 Oxford Immunotec Recent Developments
6 North America
6.1 North America Tuberculosis (TB) Diagnostics Market Size YoY Growth 2020-2031
6.2 North America Tuberculosis (TB) Diagnostics Market Facts & Figures by Country (2020-2031)
6.3 North America Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025)
6.4 North America Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Tuberculosis (TB) Diagnostics Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025)
7.4 Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025)
8 Europe
8.1 Europe Tuberculosis (TB) Diagnostics Market Size YoY Growth 2020-2031
8.2 Europe Tuberculosis (TB) Diagnostics Market Facts & Figures by Country (2020-2031)
8.3 Europe Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025)
8.4 Europe Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Tuberculosis (TB) Diagnostics Market Size YoY Growth 2020-2031
9.2 Latin America Tuberculosis (TB) Diagnostics Market Facts & Figures by Country (2020-2031)
9.3 Latin America Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025)
9.4 Latin America Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Tuberculosis (TB) Diagnostics Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Tuberculosis (TB) Diagnostics Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025)
10.4 Middle East and Africa Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Tuberculosis (TB) Diagnostics Supply Chain Analysis
11.2 Tuberculosis (TB) Diagnostics Key Raw Materials and Upstream Suppliers
11.3 Tuberculosis (TB) Diagnostics Clients Analysis
11.4 Tuberculosis (TB) Diagnostics Sales Channel and Sales Model Analysis
11.4.1 Tuberculosis (TB) Diagnostics Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Tuberculosis (TB) Diagnostics Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Tuberculosis (TB) Diagnostics Distributors
12 Tuberculosis (TB) Diagnostics Market Dynamics
12.1 Tuberculosis (TB) Diagnostics Industry Trends
12.2 Tuberculosis (TB) Diagnostics Market Drivers
12.3 Tuberculosis (TB) Diagnostics Market Challenges
12.4 Tuberculosis (TB) Diagnostics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Tuberculosis (TB) Diagnostics Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Tuberculosis (TB) Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Tuberculosis (TB) Diagnostics Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Tuberculosis (TB) Diagnostics Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Tuberculosis (TB) Diagnostics Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Tuberculosis (TB) Diagnostics Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Tuberculosis (TB) Diagnostics Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 11. Tuberculosis (TB) Diagnostics Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Tuberculosis (TB) Diagnostics Players by Revenue (US$ Million) in 2024
Table 13. Global Tuberculosis (TB) Diagnostics Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Tuberculosis (TB) Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis (TB) Diagnostics as of 2024)
Table 15. Global Tuberculosis (TB) Diagnostics Companies Headquarters
Table 16. Date of International Companies Enter into Tuberculosis (TB) Diagnostics Market
Table 17. Global Tuberculosis (TB) Diagnostics Companies Product & Service
Table 18. Global Tuberculosis (TB) Diagnostics Mergers & Acquisitions, Expansion Plans
Table 19. Danaher Corporation Information
Table 20. Danaher Description and Business Overview
Table 21. Danaher Tuberculosis (TB) Diagnostics Product
Table 22. Danaher Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Danaher Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2024
Table 24. Danaher Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2024
Table 25. Danaher Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2024
Table 26. Danaher Recent Developments
Table 27. Roche Corporation Information
Table 28. Roche Description and Business Overview
Table 29. Roche Tuberculosis (TB) Diagnostics Product
Table 30. Roche Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Roche Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2024
Table 32. Roche Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2024
Table 33. Roche Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2024
Table 34. Roche Recent Developments
Table 35. Thermo Fisher Scientific Corporation Information
Table 36. Thermo Fisher Scientific Description and Business Overview
Table 37. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product
Table 38. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Thermo Fisher Scientific Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2024
Table 40. Thermo Fisher Scientific Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2024
Table 41. Thermo Fisher Scientific Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2024
Table 42. Thermo Fisher Scientific Recent Developments
Table 43. BD Corporation Information
Table 44. BD Description and Business Overview
Table 45. BD Tuberculosis (TB) Diagnostics Product
Table 46. BD Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. BD Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2024
Table 48. BD Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2024
Table 49. BD Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2024
Table 50. BD Recent Developments
Table 51. Abbott Corporation Information
Table 52. Abbott Description and Business Overview
Table 53. Abbott Tuberculosis (TB) Diagnostics Product
Table 54. Abbott Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Abbott Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2024
Table 56. Abbott Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2024
Table 57. Abbott Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2024
Table 58. Abbott Recent Developments
Table 59. Hologic Corporation Information
Table 60. Hologic Description and Business Overview
Table 61. Hologic Tuberculosis (TB) Diagnostics Product
Table 62. Hologic Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Hologic Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2024
Table 64. Hologic Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2024
Table 65. Hologic Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2024
Table 66. Hologic Recent Developments
Table 67. Qiagen Corporation Information
Table 68. Qiagen Description and Business Overview
Table 69. Qiagen Tuberculosis (TB) Diagnostics Product
Table 70. Qiagen Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Qiagen Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2024
Table 72. Qiagen Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2024
Table 73. Qiagen Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2024
Table 74. Qiagen Recent Developments
Table 75. BioMerieux Corporation Information
Table 76. BioMerieux Description and Business Overview
Table 77. BioMerieux Tuberculosis (TB) Diagnostics Product
Table 78. BioMerieux Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. BioMerieux Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2024
Table 80. BioMerieux Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2024
Table 81. BioMerieux Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2024
Table 82. BioMerieux Recent Developments
Table 83. Hain Lifescience Corporation Information
Table 84. Hain Lifescience Description and Business Overview
Table 85. Hain Lifescience Tuberculosis (TB) Diagnostics Product
Table 86. Hain Lifescience Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Hain Lifescience Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2024
Table 88. Hain Lifescience Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2024
Table 89. Hain Lifescience Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2024
Table 90. Hain Lifescience Recent Developments
Table 91. Oxford Immunotec Corporation Information
Table 92. Oxford Immunotec Description and Business Overview
Table 93. Oxford Immunotec Tuberculosis (TB) Diagnostics Product
Table 94. Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Oxford Immunotec Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2024
Table 96. Oxford Immunotec Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2024
Table 97. Oxford Immunotec Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2024
Table 98. Oxford Immunotec Recent Developments
Table 99. North America Tuberculosis (TB) Diagnostics Revenue by Country (2020-2025) & (US$ Million)
Table 100. North America Tuberculosis (TB) Diagnostics Revenue by Country (2026-2031) & (US$ Million)
Table 101. North America Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 102. North America Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 103. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Region (2020-2025) & (US$ Million)
Table 104. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Region (2026-2031) & (US$ Million)
Table 105. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 106. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 107. Europe Tuberculosis (TB) Diagnostics Revenue by Country (2020-2025) & (US$ Million)
Table 108. Europe Tuberculosis (TB) Diagnostics Revenue by Country (2026-2031) & (US$ Million)
Table 109. Europe Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 110. Europe Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 111. Latin America Tuberculosis (TB) Diagnostics Revenue by Country (2020-2025) & (US$ Million)
Table 112. Latin America Tuberculosis (TB) Diagnostics Revenue by Country (2026-2031) & (US$ Million)
Table 113. Latin America Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 114. Latin America Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 115. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue by Country (2020-2025) & (US$ Million)
Table 116. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue by Country (2026-2031) & (US$ Million)
Table 117. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 118. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 119. Tuberculosis (TB) Diagnostics Key Raw Materials, Industry Status and Trend
Table 120. Tuberculosis (TB) Diagnostics Key Raw Materials and Upstream Suppliers
Table 121. Tuberculosis (TB) Diagnostics Clients Status and Trend
Table 122. Tuberculosis (TB) Diagnostics Typical Clients
Table 123. Tuberculosis (TB) Diagnostics Distributors
Table 124. Tuberculosis (TB) Diagnostics Market Trends
Table 125. Tuberculosis (TB) Diagnostics Market Drivers
Table 126. Tuberculosis (TB) Diagnostics Market Challenges
Table 127. Tuberculosis (TB) Diagnostics Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Tuberculosis (TB) Diagnostics Product Picture
Figure 2. Global Tuberculosis (TB) Diagnostics Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type in 2024 & 2031
Figure 4. Culture-Based Diagnostics Product Picture
Figure 5. Sputum Smear Microscopy Product Picture
Figure 6. Rapid Molecular Diagnostics Product Picture
Figure 7. Others Product Picture
Figure 8. Global Tuberculosis (TB) Diagnostics Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application in 2024 & 2031
Figure 10. Diagnostic Laboratories
Figure 11. Hospitals
Figure 12. Tuberculosis (TB) Diagnostics Report Years Considered
Figure 13. Global Tuberculosis (TB) Diagnostics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Tuberculosis (TB) Diagnostics Market Size (2020-2031) & (US$ Million)
Figure 15. Global Tuberculosis (TB) Diagnostics Market Size Market Share by Region: 2024 Versus 2031
Figure 16. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Region (2020-2031)
Figure 17. Global Tuberculosis (TB) Diagnostics Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Global Tuberculosis (TB) Diagnostics Revenue Market Share Forecast by Application (2020-2031)
Figure 19. Culture-Based Diagnostics of Tuberculosis (TB) Diagnostics Revenue Market Share by Application, 2024 VS 2031
Figure 20. Sputum Smear Microscopy of Tuberculosis (TB) Diagnostics Revenue Market Share by Application, 2024 VS 2031
Figure 21. Rapid Molecular Diagnostics of Tuberculosis (TB) Diagnostics Revenue Market Share by Application, 2024 VS 2031
Figure 22. Others of Tuberculosis (TB) Diagnostics Revenue Market Share by Application, 2024 VS 2031
Figure 23. Tuberculosis (TB) Diagnostics Revenue Share by Company (2024)
Figure 24. Tuberculosis (TB) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Culture-Based Diagnostics Revenue Proportion by Company in 2024
Figure 26. Sputum Smear Microscopy Revenue Proportion by Company in 2024
Figure 27. Rapid Molecular Diagnostics Revenue Proportion by Company in 2024
Figure 28. Others Revenue Proportion by Company in 2024
Figure 29. North America Tuberculosis (TB) Diagnostics Revenue 2020-2031 (US$ Million)
Figure 30. North America Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2025)
Figure 31. North America Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2025)
Figure 32. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue 2020-2031 (US$ Million)
Figure 33. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2025)
Figure 36. Europe Tuberculosis (TB) Diagnostics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Tuberculosis (TB) Diagnostics Revenue Market Share by Country (2020-2031)
Figure 38. Europe Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2025)
Figure 39. Europe Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2025)
Figure 40. Latin America Tuberculosis (TB) Diagnostics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Latin America Tuberculosis (TB) Diagnostics Revenue Market Share by Country (2020-2031)
Figure 42. Latin America Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2025)
Figure 43. Latin America Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2025)
Figure 44. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue Market Share by Country (2020-2031)
Figure 46. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2025)
Figure 47. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2025)
Figure 48. Tuberculosis (TB) Diagnostics Supply Chain (Upstream and Downstream Market)
Figure 49. Global Production Market Share of Tuberculosis (TB) Diagnostics Raw Materials by Region in 2024
Figure 50. Tuberculosis (TB) Diagnostics Distribution Channels
Figure 51. Global Tuberculosis (TB) Diagnostics Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 52. Global Tuberculosis (TB) Diagnostics Percentage 2020-2031: Online Sales VS Offline Sales
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Table 1. Global Tuberculosis (TB) Diagnostics Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Tuberculosis (TB) Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Tuberculosis (TB) Diagnostics Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Tuberculosis (TB) Diagnostics Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Tuberculosis (TB) Diagnostics Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Tuberculosis (TB) Diagnostics Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Tuberculosis (TB) Diagnostics Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 11. Tuberculosis (TB) Diagnostics Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Tuberculosis (TB) Diagnostics Players by Revenue (US$ Million) in 2024
Table 13. Global Tuberculosis (TB) Diagnostics Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Tuberculosis (TB) Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis (TB) Diagnostics as of 2024)
Table 15. Global Tuberculosis (TB) Diagnostics Companies Headquarters
Table 16. Date of International Companies Enter into Tuberculosis (TB) Diagnostics Market
Table 17. Global Tuberculosis (TB) Diagnostics Companies Product & Service
Table 18. Global Tuberculosis (TB) Diagnostics Mergers & Acquisitions, Expansion Plans
Table 19. Danaher Corporation Information
Table 20. Danaher Description and Business Overview
Table 21. Danaher Tuberculosis (TB) Diagnostics Product
Table 22. Danaher Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Danaher Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2024
Table 24. Danaher Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2024
Table 25. Danaher Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2024
Table 26. Danaher Recent Developments
Table 27. Roche Corporation Information
Table 28. Roche Description and Business Overview
Table 29. Roche Tuberculosis (TB) Diagnostics Product
Table 30. Roche Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Roche Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2024
Table 32. Roche Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2024
Table 33. Roche Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2024
Table 34. Roche Recent Developments
Table 35. Thermo Fisher Scientific Corporation Information
Table 36. Thermo Fisher Scientific Description and Business Overview
Table 37. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product
Table 38. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Thermo Fisher Scientific Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2024
Table 40. Thermo Fisher Scientific Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2024
Table 41. Thermo Fisher Scientific Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2024
Table 42. Thermo Fisher Scientific Recent Developments
Table 43. BD Corporation Information
Table 44. BD Description and Business Overview
Table 45. BD Tuberculosis (TB) Diagnostics Product
Table 46. BD Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. BD Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2024
Table 48. BD Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2024
Table 49. BD Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2024
Table 50. BD Recent Developments
Table 51. Abbott Corporation Information
Table 52. Abbott Description and Business Overview
Table 53. Abbott Tuberculosis (TB) Diagnostics Product
Table 54. Abbott Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Abbott Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2024
Table 56. Abbott Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2024
Table 57. Abbott Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2024
Table 58. Abbott Recent Developments
Table 59. Hologic Corporation Information
Table 60. Hologic Description and Business Overview
Table 61. Hologic Tuberculosis (TB) Diagnostics Product
Table 62. Hologic Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Hologic Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2024
Table 64. Hologic Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2024
Table 65. Hologic Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2024
Table 66. Hologic Recent Developments
Table 67. Qiagen Corporation Information
Table 68. Qiagen Description and Business Overview
Table 69. Qiagen Tuberculosis (TB) Diagnostics Product
Table 70. Qiagen Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Qiagen Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2024
Table 72. Qiagen Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2024
Table 73. Qiagen Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2024
Table 74. Qiagen Recent Developments
Table 75. BioMerieux Corporation Information
Table 76. BioMerieux Description and Business Overview
Table 77. BioMerieux Tuberculosis (TB) Diagnostics Product
Table 78. BioMerieux Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. BioMerieux Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2024
Table 80. BioMerieux Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2024
Table 81. BioMerieux Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2024
Table 82. BioMerieux Recent Developments
Table 83. Hain Lifescience Corporation Information
Table 84. Hain Lifescience Description and Business Overview
Table 85. Hain Lifescience Tuberculosis (TB) Diagnostics Product
Table 86. Hain Lifescience Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Hain Lifescience Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2024
Table 88. Hain Lifescience Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2024
Table 89. Hain Lifescience Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2024
Table 90. Hain Lifescience Recent Developments
Table 91. Oxford Immunotec Corporation Information
Table 92. Oxford Immunotec Description and Business Overview
Table 93. Oxford Immunotec Tuberculosis (TB) Diagnostics Product
Table 94. Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Oxford Immunotec Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2024
Table 96. Oxford Immunotec Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2024
Table 97. Oxford Immunotec Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2024
Table 98. Oxford Immunotec Recent Developments
Table 99. North America Tuberculosis (TB) Diagnostics Revenue by Country (2020-2025) & (US$ Million)
Table 100. North America Tuberculosis (TB) Diagnostics Revenue by Country (2026-2031) & (US$ Million)
Table 101. North America Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 102. North America Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 103. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Region (2020-2025) & (US$ Million)
Table 104. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Region (2026-2031) & (US$ Million)
Table 105. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 106. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 107. Europe Tuberculosis (TB) Diagnostics Revenue by Country (2020-2025) & (US$ Million)
Table 108. Europe Tuberculosis (TB) Diagnostics Revenue by Country (2026-2031) & (US$ Million)
Table 109. Europe Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 110. Europe Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 111. Latin America Tuberculosis (TB) Diagnostics Revenue by Country (2020-2025) & (US$ Million)
Table 112. Latin America Tuberculosis (TB) Diagnostics Revenue by Country (2026-2031) & (US$ Million)
Table 113. Latin America Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 114. Latin America Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 115. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue by Country (2020-2025) & (US$ Million)
Table 116. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue by Country (2026-2031) & (US$ Million)
Table 117. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 118. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 119. Tuberculosis (TB) Diagnostics Key Raw Materials, Industry Status and Trend
Table 120. Tuberculosis (TB) Diagnostics Key Raw Materials and Upstream Suppliers
Table 121. Tuberculosis (TB) Diagnostics Clients Status and Trend
Table 122. Tuberculosis (TB) Diagnostics Typical Clients
Table 123. Tuberculosis (TB) Diagnostics Distributors
Table 124. Tuberculosis (TB) Diagnostics Market Trends
Table 125. Tuberculosis (TB) Diagnostics Market Drivers
Table 126. Tuberculosis (TB) Diagnostics Market Challenges
Table 127. Tuberculosis (TB) Diagnostics Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Tuberculosis (TB) Diagnostics Product Picture
Figure 2. Global Tuberculosis (TB) Diagnostics Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type in 2024 & 2031
Figure 4. Culture-Based Diagnostics Product Picture
Figure 5. Sputum Smear Microscopy Product Picture
Figure 6. Rapid Molecular Diagnostics Product Picture
Figure 7. Others Product Picture
Figure 8. Global Tuberculosis (TB) Diagnostics Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application in 2024 & 2031
Figure 10. Diagnostic Laboratories
Figure 11. Hospitals
Figure 12. Tuberculosis (TB) Diagnostics Report Years Considered
Figure 13. Global Tuberculosis (TB) Diagnostics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Tuberculosis (TB) Diagnostics Market Size (2020-2031) & (US$ Million)
Figure 15. Global Tuberculosis (TB) Diagnostics Market Size Market Share by Region: 2024 Versus 2031
Figure 16. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Region (2020-2031)
Figure 17. Global Tuberculosis (TB) Diagnostics Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Global Tuberculosis (TB) Diagnostics Revenue Market Share Forecast by Application (2020-2031)
Figure 19. Culture-Based Diagnostics of Tuberculosis (TB) Diagnostics Revenue Market Share by Application, 2024 VS 2031
Figure 20. Sputum Smear Microscopy of Tuberculosis (TB) Diagnostics Revenue Market Share by Application, 2024 VS 2031
Figure 21. Rapid Molecular Diagnostics of Tuberculosis (TB) Diagnostics Revenue Market Share by Application, 2024 VS 2031
Figure 22. Others of Tuberculosis (TB) Diagnostics Revenue Market Share by Application, 2024 VS 2031
Figure 23. Tuberculosis (TB) Diagnostics Revenue Share by Company (2024)
Figure 24. Tuberculosis (TB) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Culture-Based Diagnostics Revenue Proportion by Company in 2024
Figure 26. Sputum Smear Microscopy Revenue Proportion by Company in 2024
Figure 27. Rapid Molecular Diagnostics Revenue Proportion by Company in 2024
Figure 28. Others Revenue Proportion by Company in 2024
Figure 29. North America Tuberculosis (TB) Diagnostics Revenue 2020-2031 (US$ Million)
Figure 30. North America Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2025)
Figure 31. North America Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2025)
Figure 32. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue 2020-2031 (US$ Million)
Figure 33. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2025)
Figure 36. Europe Tuberculosis (TB) Diagnostics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Tuberculosis (TB) Diagnostics Revenue Market Share by Country (2020-2031)
Figure 38. Europe Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2025)
Figure 39. Europe Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2025)
Figure 40. Latin America Tuberculosis (TB) Diagnostics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Latin America Tuberculosis (TB) Diagnostics Revenue Market Share by Country (2020-2031)
Figure 42. Latin America Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2025)
Figure 43. Latin America Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2025)
Figure 44. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue Market Share by Country (2020-2031)
Figure 46. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2025)
Figure 47. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2025)
Figure 48. Tuberculosis (TB) Diagnostics Supply Chain (Upstream and Downstream Market)
Figure 49. Global Production Market Share of Tuberculosis (TB) Diagnostics Raw Materials by Region in 2024
Figure 50. Tuberculosis (TB) Diagnostics Distribution Channels
Figure 51. Global Tuberculosis (TB) Diagnostics Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 52. Global Tuberculosis (TB) Diagnostics Percentage 2020-2031: Online Sales VS Offline Sales
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232